VRTX vs WSFS · P/E 30, rev $12.00B vs P/E 13, rev $348.5M
Vertex Pharmaceuticals Inc (VRTX) versus WSFS Financial Corporation (WSFS) — a side-by-side from cached financials, not a winner call.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
WSFS Financial Corporation (WSFS) is a banks - regional company listed on US.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Latest reported WSFS revenue for 2023-06-30 was $348.5M. Net income was $68.6M. Revenue was up 20.4% from 2023-03-31 to 2023-06-30. WSFS currently screens at market cap $3.35B and trailing P/E 13.3.
VRTX currently screens at market cap $106.87B and trailing P/E 29.7. WSFS currently screens at market cap $3.35B and trailing P/E 13.3.
Not investment advice. Open the VRTX and WSFS stock pages for the full models.
Not investment advice.